BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35815452)

  • 1. Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.
    Ishikawa T; Kodama E; Kobayashi T; Azumi M; Nozawa Y; Iwanaga A; Sano T; Honma T
    Ann Palliat Med; 2022 Aug; 11(8):2658-2667. PubMed ID: 35815452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis.
    Nishikawa H; Enomoto H; Yoh K; Iwata Y; Sakai Y; Kishino K; Ikeda N; Takashima T; Aizawa N; Takata R; Hasegawa K; Ishii N; Yuri Y; Nishimura T; Iijima H; Nishiguchi S
    Medicine (Baltimore); 2019 Dec; 98(50):e18366. PubMed ID: 31852142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Wu PS; Hsieh YC; Lee PC; Yang TC; Chen YJ; Yang YY; Huang HC; Hsu SJ; Huo TI; Lee KC; Lin HC; Hou MC
    Dig Dis; 2024; 42(2):166-177. PubMed ID: 38219719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Mac-2-binding protein glycosylation isomer level with nutritional status in chronic liver disease.
    Eso Y; Takai A; Taura K; Takahashi K; Ueda Y; Marusawa H; Seno H
    J Gastroenterol Hepatol; 2018 Feb; ():. PubMed ID: 29473206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study.
    Park HJ; Seo KI; Lee SU; Han BH; Yun BC; Park ET; Lee J; Hwang H; Yoon M
    Medicine (Baltimore); 2022 Oct; 101(40):e30489. PubMed ID: 36221351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases.
    Moon HW; Park M; Hur M; Kim H; Choe WH; Yun YM
    Ann Lab Med; 2018 Jul; 38(4):331-337. PubMed ID: 29611383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.
    Aslan S; Eryuruk U; Tasdemir MN; Cakir IM
    Abdom Radiol (NY); 2022 Jul; 47(7):2325-2334. PubMed ID: 35672474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases.
    Jang SY; Tak WY; Park SY; Kweon YO; Lee YR; Kim G; Hur K; Han MH; Lee WK
    Ann Lab Med; 2021 May; 41(3):302-309. PubMed ID: 33303715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients.
    Sulaiman AS; Hasan I; Lesmana CRA; Kurniawan J; Jasirwan COM; Nababan S; Kalista KF; Hanifa RS; Rachmani D; Gani RA
    Acta Med Indones; 2022 Oct; 54(4):567-573. PubMed ID: 36624717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.
    Yamashita Y; Umemura T; Kimura T; Joshita S; Hirohara J; Nakano T; Komori A; Tanaka A
    JHEP Rep; 2023 Apr; 5(4):100662. PubMed ID: 36873419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Mac-2 binding protein glycosylation isomer predicts the activation of hepatic stellate cells after liver transplantation.
    Yamada N; Katano T; Hirata Y; Okada N; Sanada Y; Ihara Y; Urahashi T; Ushijima K; Karasawa T; Takahashi M; Mizuta K
    J Gastroenterol Hepatol; 2019 Feb; 34(2):418-424. PubMed ID: 30101431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation.
    Kimura Y; Taura K; Hai Nam N; Uemoto Y; Yoshino K; Ikeno Y; Okuda Y; Nishio T; Yamamoto G; Tanabe K; Koyama Y; Anazawa T; Fukumitsu K; Ito T; Yagi S; Kamo N; Seo S; Iwaisako K; Hata K; Imai T; Uemoto S
    Liver Transpl; 2021 Feb; 27(3):403-415. PubMed ID: 32780942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Bui HH; Nguyen ST; Phan ST; Nguyen KM; Nguyen CD
    Dig Dis Sci; 2023 Dec; 68(12):4407-4417. PubMed ID: 37861877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.
    Zhong CR; Qiu JL; Yuan YC; Qiu ZY; Li K; Wang CW; Shi YX; Li KR; Lin Z; Huang ZK; He W; Li BK; Yuan YF
    Am J Cancer Res; 2022; 12(6):2711-2720. PubMed ID: 35812041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of Mac-2-binding protein glycosylation isomer (M2BPGi) as a liver fibrosis marker in chronic hepatitis C patients with chronic kidney disease on hemodialysis.
    Sulaiman AS; Hasan I; Hustrini NM; Lydia A; Hanifa RS; Gani RA
    Clin Exp Nephrol; 2023 Jun; 27(6):557-564. PubMed ID: 36995542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.
    Mak LY; Wong DK; Seto WK; Ning Q; Cheung KS; Fung J; Lai CL; Yuen MF
    Hepatol Int; 2019 Mar; 13(2):148-156. PubMed ID: 30671807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
    Hiraoka A; Kato M; Marui K; Murakami T; Onishi K; Adachi T; Matsuoka J; Ueki H; Yoshino T; Tsuruta M; Aibiki T; Okudaira T; Kuroda T; Iwasaki R; Suga Y; Miyata H; Ninomiya T; Hirooka M; Abe M; Matsuura B; Michitaka K; Hiasa Y
    Cancer Med; 2021 Jun; 10(11):3584-3592. PubMed ID: 33960691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
    Chen Q; Zhong R; Wang Y; Kui Y; Wen X; Huang J; Jin Q
    Dig Dis; 2023; 41(6):946-956. PubMed ID: 37321186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia.
    Yamada N; Sanada Y; Tashiro M; Hirata Y; Okada N; Ihara Y; Urahashi T; Mizuta K
    J Gastroenterol; 2017 Feb; 52(2):245-252. PubMed ID: 27349650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.